EAM
NKGN

Exos Asset Management’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

Exos Asset Management’s Portfolio NKGN Stock Details NKGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		$699K Buy
+71,939
New +$699K 0.36% 87
2022
Q1 		– Sell
-70,000
Closed -$678K – 331
2021
Q4 		$678K Hold
70,000
– – 0.35% 96
2021
Q3 		$678K Buy
+70,000
New +$678K 0.36% 84